A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital, Taiwan
Tata Memorial Hospital
Tata Memorial Hospital
Armed Forces Institute of Pathology Rawalpindi
Coordinación de Investigación en Salud, Mexico
Tata Memorial Hospital
Bangladesh Reference Institute of Chemical Measurements (BRICM)
Turku University Hospital
Liverpool University Hospitals NHS Foundation Trust
Turku University Hospital
International Atomic Energy Agency
Turku University Hospital
Henan Cancer Hospital
Instituto Nacional de Cancer, Brazil
East and North Hertfordshire NHS Trust
Theagenio Cancer Hospital
Tata Memorial Hospital